新明中國(02699.HK)仍未能支付3億元欠款
新明中國(02699.HK)公布,就有關公司於6月1日到期之可換股債券,涉及公司未能支付之3億元本金及相關利息,至今,公司仍未結清欠款。
公司獲悉,德勤於11月18日獲Chance Talent委任為新明中國控股股東Xinxing持有的9.4億股股份的共同及個別接管人。因此,Xinxing的董事對押記財產的管理權已暫停,且公司在未經接管人事先書面同意的情況下不會對押記股份的任何轉讓進行登記。
公司董事會被要求於收到接管人信件起計七日內,確認其同意委任由接管人提名的一名董事會觀察員。
於10月27日,Xinxing向北控城投香港出售5.54億股份,相當於已發行股本29.5%,名義代價1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.